These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18384652)

  • 21. Laboratory Testing for von Willebrand Factor Collagen Binding (VWF:CB).
    Favaloro EJ; Mohammed S
    Methods Mol Biol; 2017; 1646():417-433. PubMed ID: 28804845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of multimer organization of von Willebrand factor in an acquired von Willebrand syndrome.
    Casonato A; Pontara E; Doria A; Bertomoro A; Cattini MG; Gambari PF; Girolami A
    Br J Haematol; 2002 Mar; 116(4):899-904. PubMed ID: 11886398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet von Willebrand factor: evidence for its involvement in platelet adhesion to collagen.
    Fressinaud E; Baruch D; Rothschild C; Baumgartner HR; Meyer D
    Blood; 1987 Oct; 70(4):1214-7. PubMed ID: 3498520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unmet Need for Reliable Immunological Detection Method for Anti-von Willebrand Factor Autoantibodies.
    Osaki T; Souri M; Yokoyama C; Magari Y; Ichinose A
    Thromb Haemost; 2023 Apr; 123(4):478-481. PubMed ID: 36539201
    [No Abstract]   [Full Text] [Related]  

  • 25. Analysis of von Willebrand factor in platelets of patients with various forms of von Willebrand disease: is there a clinical relevance?
    Kertzscher F; Müller AE; Lenk H
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S177-9. PubMed ID: 10650864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An atypical manifestation of acquired von Willebrand syndrome (AVWS) associated with systemic lupus erythematosus (SLE).
    Kasatkar P; Ghosh K; Shetty S
    Ann Hematol; 2014 Jan; 93(1):173-5. PubMed ID: 23625134
    [No Abstract]   [Full Text] [Related]  

  • 27. Are increased levels of von Willebrand factor in chronic coronary heart disease caused by decrease in von Willebrand factor cleaving protease activity? A study by an immunoassay with antibody against intact bond 842Tyr-843Met of the von Willebrand factor protein.
    He S; Cao H; Magnusson CG; Eriksson-Berg M; Mehrkash M; Schenck-Gustafsson K; Blombäck M
    Thromb Res; 2001 Aug; 103(3):241-8. PubMed ID: 11672586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of high-dose intravenous gamma-globulin in acquired von Willebrand syndrome.
    Macik BG; Gabriel DA; White GC; High K; Roberts H
    Arch Pathol Lab Med; 1988 Feb; 112(2):143-6. PubMed ID: 2447856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Collagen-binding of von Willebrand's factor antigen in the classification of von Willebrand's disease.
    Duggan MJ; DiMichele DM; Christian MJ; Fink LM; Hathaway WE
    Am J Clin Pathol; 1987 Jul; 88(1):97-102. PubMed ID: 3496781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
    Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
    Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquired von Willebrand syndrome: an update.
    Franchini M; Lippi G
    Am J Hematol; 2007 May; 82(5):368-75. PubMed ID: 17133419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of von Willebrand factor activity with collagen-binding assay and diagnosis of von Willebrand disease: effect of collagen source and coating conditions.
    Paczuski R
    J Lab Clin Med; 2002 Oct; 140(4):250-4. PubMed ID: 12389023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor VIII/von Willebrand factor binding to von Willebrand's disease platelets.
    Gralnick HR; Williams SB; Shafer BC; Corash L
    Blood; 1982 Aug; 60(2):328-32. PubMed ID: 6807372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The pathogenesis of acquired von Willebrand's disease in a patient with asymptomatic monoclonal gammopathy; malignant lymphoma developing 30 months after onset of bruising].
    Takai Y; Hayasi H; Tsurumi N; Tsuda T; Fujlta T; Ohnoshi T; Kimura I
    Rinsho Ketsueki; 1987 Jan; 28(1):53-64. PubMed ID: 3494863
    [No Abstract]   [Full Text] [Related]  

  • 35. The von Willebrand syndrome.
    Bloom AL
    Semin Hematol; 1980 Oct; 17(4):215-27. PubMed ID: 6160617
    [No Abstract]   [Full Text] [Related]  

  • 36. von Willebrand factor collagen binding assay with a commercial kit using type III collagen in von Willebrand disease type 2.
    Veyradier A; Trossaert M; Lefrancois A; Fressinaud E; Meyer D
    J Thromb Haemost; 2007 Apr; 5(4):868-70. PubMed ID: 17408416
    [No Abstract]   [Full Text] [Related]  

  • 37. Continuous infusion of human plasma-derived von Willebrand factor concentrate as an effective therapy in a patient with acquired von Willebrand disease.
    Patel SB; Rodgers GM
    Haemophilia; 2014 Nov; 20(6):e411-4. PubMed ID: 25333342
    [No Abstract]   [Full Text] [Related]  

  • 38. Leu 697-->Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand disease.
    Hilbert L; Gaucher C; de Romeuf C; Horellou MH; Vink T; Mazurier C
    Blood; 1994 Mar; 83(6):1542-50. PubMed ID: 8123843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homozygous gene conversion in von Willebrand factor gene as a cause of type 3 von Willebrand disease and predisposition to inhibitor development.
    Surdhar GK; Enayat MS; Lawson S; Williams MD; Hill FG
    Blood; 2001 Jul; 98(1):248-50. PubMed ID: 11439975
    [No Abstract]   [Full Text] [Related]  

  • 40. Effectiveness of high-dose intravenous gamma globulin therapy in acquired von Willebrand's disease.
    van Genderen PJ; Michiels JJ; Bakker JJ; van 't Veer MB
    Vox Sang; 1994; 67(1):14-7. PubMed ID: 7975445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.